245 related articles for article (PubMed ID: 30030836)
21. Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1.
Matsushita K; Kitamura K; Rahmutulla B; Tanaka N; Ishige T; Satoh M; Hoshino T; Miyagi S; Mori T; Itoga S; Shimada H; Tomonaga T; Kito M; Nakajima-Takagi Y; Kubo S; Nakaseko C; Hatano M; Miki T; Matsuo M; Fukuyo M; Kaneda A; Iwama A; Nomura F
Oncotarget; 2015 Mar; 6(7):5102-17. PubMed ID: 25671302
[TBL] [Abstract][Full Text] [Related]
22. Sirtuin 1 Activation Suppresses the Growth of T-lymphoblastic Leukemia Cells by Inhibiting NOTCH and NF-κB Pathways.
Okasha SM; Itoh M; Tohda S
Anticancer Res; 2020 Jun; 40(6):3155-3161. PubMed ID: 32487610
[TBL] [Abstract][Full Text] [Related]
23. Convergence of the ZMIZ1 and NOTCH1 pathways at C-MYC in acute T lymphoblastic leukemias.
Rakowski LA; Garagiola DD; Li CM; Decker M; Caruso S; Jones M; Kuick R; Cierpicki T; Maillard I; Chiang MY
Cancer Res; 2013 Jan; 73(2):930-41. PubMed ID: 23161489
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic antibody targeting of individual Notch receptors.
Wu Y; Cain-Hom C; Choy L; Hagenbeek TJ; de Leon GP; Chen Y; Finkle D; Venook R; Wu X; Ridgway J; Schahin-Reed D; Dow GJ; Shelton A; Stawicki S; Watts RJ; Zhang J; Choy R; Howard P; Kadyk L; Yan M; Zha J; Callahan CA; Hymowitz SG; Siebel CW
Nature; 2010 Apr; 464(7291):1052-7. PubMed ID: 20393564
[TBL] [Abstract][Full Text] [Related]
25. Notch-ing from T-cell to B-cell lymphoid malignancies.
Mirandola L; Comi P; Cobos E; Kast WM; Chiriva-Internati M; Chiaramonte R
Cancer Lett; 2011 Sep; 308(1):1-13. PubMed ID: 21652011
[TBL] [Abstract][Full Text] [Related]
26. Constitutive activation of NF-κB signaling by NOTCH1 mutations in chronic lymphocytic leukemia.
Xu ZS; Zhang JS; Zhang JY; Wu SQ; Xiong DL; Chen HJ; Chen ZZ; Zhan R
Oncol Rep; 2015 Apr; 33(4):1609-14. PubMed ID: 25633905
[TBL] [Abstract][Full Text] [Related]
27. FHL1C induces apoptosis in Notch1-dependent T-ALL cells through an interaction with RBP-J.
Fu W; Wang K; Zhao JL; Yu HC; Li SZ; Lin Y; Liang L; Huang SY; Liang YM; Han H; Qin HY
BMC Cancer; 2014 Jun; 14():463. PubMed ID: 24952875
[TBL] [Abstract][Full Text] [Related]
28. Notch signaling promotes disease initiation and progression in murine chronic lymphocytic leukemia.
Tardivon D; Antoszewski M; Zangger N; Nkosi M; Sordet-Dessimoz J; Hendriks R; Koch U; Radtke F
Blood; 2021 Jun; 137(22):3079-3092. PubMed ID: 33512383
[TBL] [Abstract][Full Text] [Related]
29. DDX5 is a positive regulator of oncogenic NOTCH1 signaling in T cell acute lymphoblastic leukemia.
Lin S; Tian L; Shen H; Gu Y; Li JL; Chen Z; Sun X; You MJ; Wu L
Oncogene; 2013 Oct; 32(40):4845-53. PubMed ID: 23108395
[TBL] [Abstract][Full Text] [Related]
30. Cdc73 protects Notch-induced T-cell leukemia cells from DNA damage and mitochondrial stress.
Melnick AF; Mullin C; Lin K; McCarter AC; Liang S; Liu YE; Wang Q; Jerome NA; Choe E; Kunnath N; Bodanapu G; Akter F; Magnuson B; Kumar S; Lombard DB; Muntean AG; Ljungman M; Sekiguchi J; Ryan RJH; Chiang MY
Blood; 2023 Dec; 142(25):2159-2174. PubMed ID: 37616559
[TBL] [Abstract][Full Text] [Related]
31. Elevated TRIB2 with NOTCH1 activation in paediatric/adult T-ALL.
Hannon MM; Lohan F; Erbilgin Y; Sayitoglu M; O'Hagan K; Mills K; Ozbek U; Keeshan K
Br J Haematol; 2012 Sep; 158(5):626-34. PubMed ID: 22775572
[TBL] [Abstract][Full Text] [Related]
32. Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia.
Mirandola L; Chiriva-Internati M; Montagna D; Locatelli F; Zecca M; Ranzani M; Basile A; Locati M; Cobos E; Kast WM; Asselta R; Paraboschi EM; Comi P; Chiaramonte R
J Pathol; 2012 Apr; 226(5):713-22. PubMed ID: 21984373
[TBL] [Abstract][Full Text] [Related]
33. Mutations in the HD and PEST domain of Notch-1 receptor in T-cell acute lymphoblastic leukemia: report of novel mutations from Indian population.
Bhanushali AA; Babu S; Thangapandi VR; Pillai R; Chheda P; Das BR
Oncol Res; 2010; 19(2):99-104. PubMed ID: 21302811
[TBL] [Abstract][Full Text] [Related]
34. CAD204520 Targets
Pagliaro L; Cerretani E; Vento F; Montanaro A; Moron Dalla Tor L; Simoncini E; Giaimo M; Gherli A; Zamponi R; Tartaglione I; Lorusso B; Scita M; Russo F; Sammarelli G; Todaro G; Silini EM; Rigolin GM; Quaini F; Cuneo A; Roti G
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255842
[No Abstract] [Full Text] [Related]
35. Recent advances on NOTCH signaling in T-ALL.
Tzoneva G; Ferrando AA
Curr Top Microbiol Immunol; 2012; 360():163-82. PubMed ID: 22673746
[TBL] [Abstract][Full Text] [Related]
36. The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia.
Mendes RD; Canté-Barrett K; Pieters R; Meijerink JP
Haematologica; 2016 Sep; 101(9):1010-7. PubMed ID: 27582570
[TBL] [Abstract][Full Text] [Related]
37. NOTCH is a key regulator of human T-cell acute leukemia initiating cell activity.
Armstrong F; Brunet de la Grange P; Gerby B; Rouyez MC; Calvo J; Fontenay M; Boissel N; Dombret H; Baruchel A; Landman-Parker J; Roméo PH; Ballerini P; Pflumio F
Blood; 2009 Feb; 113(8):1730-40. PubMed ID: 18984862
[TBL] [Abstract][Full Text] [Related]
38. An activating intragenic deletion in NOTCH1 in human T-ALL.
Haydu JE; De Keersmaecker K; Duff MK; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Ferrando A
Blood; 2012 May; 119(22):5211-4. PubMed ID: 22510873
[TBL] [Abstract][Full Text] [Related]
39. Notch in T-ALL: new players in a complex disease.
Koch U; Radtke F
Trends Immunol; 2011 Sep; 32(9):434-42. PubMed ID: 21775206
[TBL] [Abstract][Full Text] [Related]
40. Extension of the Notch intracellular domain ankyrin repeat stack by NRARP promotes feedback inhibition of Notch signaling.
Jarrett SM; Seegar TCM; Andrews M; Adelmant G; Marto JA; Aster JC; Blacklow SC
Sci Signal; 2019 Nov; 12(606):. PubMed ID: 31690634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]